3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
16
Gynecologic
3
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
Conditions
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Small Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
38
Docetaxel
23
Paclitaxel
20
Trastuzumab
19
Cyclophosphamide
18
Gemcitabine
17
Carboplatin
17
Magnetic Resonance Spectroscopy
16
Radiotherapy
14
Nivolumab
13
Radiosurgery
12
Surveys and Questionnaires
11
Specimen Handling
10
Fulvestrant
10
fludarabine
9
aldesleukin
9
Vinorelbine
9
Blood Specimen Collection
9
Taxes
8
Injections
8
Drug Therapy
8
Cisplatin
8
Capecitabine
8
Bevacizumab
8
Standard of Care
7
Psychiatric Rehabilitation
7
Fluorodeoxyglucose F18
7
Early Intervention, Educational
7
sargramostim
6
palbociclib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Mass Spectrometry
×
Thoracic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled